NCT00370929

Brief Summary

Epileptic seizures may occur at times of stress and commonly increase life stress. This study will evaluate whether meditation improves seizure control and quality of life for individuals with uncontrolled epilepsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2006

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2006

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

July 22, 2016

Status Verified

July 1, 2016

Enrollment Period

1.7 years

First QC Date

August 30, 2006

Last Update Submit

July 20, 2016

Conditions

Epilepsy

Outcome Measures

Primary Outcomes (2)

  • Seizure frequency

    20 weeks

  • Quality of Life

    20 weeks

Secondary Outcomes (4)

  • Mood

    20 weeks

  • Affect

    20 weeks

  • Anxiety

    20 weeks

  • Sleep quality

    20 weeks

Study Arms (1)

Meditation

EXPERIMENTAL
Behavioral: Meditation

Interventions

MeditationBEHAVIORAL
Meditation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • or more seizures per month
  • ability to participate in meditation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geffen School of Medicine at UCLA

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Epilepsy

Interventions

Meditation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • John Stern, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 30, 2006

First Posted

September 1, 2006

Study Start

May 1, 2006

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

July 22, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share

Locations

US(1)